MIXOHIPRA-H
MIXOHIPRA-H
Authorised
- Myxoma virus, strain VMI 30, Live
Product identification
Medicine name:
MIXOHIPRA-H
Active substance:
- Myxoma virus, strain VMI 30, Live
Target species:
-
Rabbit
Route of administration:
-
Intradermal use
-
Subcutaneous use
Product details
Active substance and strength:
-
Myxoma virus, strain VMI 30, Live3.00/cell culture infective dose 500.50millilitre(s)
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intradermal use
- Rabbit
-
Meat and offal0day
-
-
Subcutaneous use
- Rabbit
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI08AD02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Hipra S.A.
Responsible authority:
- (AEMPS)
Authorisation number:
- 2919 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
